Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Satellos Bioscience Inc. (MSCLF) Debt to Capital Ratio data is not available for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-5.61M |
|
-- |
|
-- |
|
$6.37M |
|
$-6.37M |
|
$0.79M |
|
$-5.58M |
|
$-5.58M |
|
$-5.61M |
|
$-5.61M |
|
$-5.61M |
|
$-5.61M |
|
$-6.37M |
|
$-6.37M |
|
171.23M |
|
171.23M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$41.11M |
|
$0.01M |
|
$0.01M |
|
$41.12M |
|
$2.77M |
|
-- |
|
-- |
|
$2.77M |
|
$38.35M |
|
$38.35M |
|
$38.35M |
|
176.31M |
|
| Cash Flow Statement Financials | |
$-12.21M |
|
$8.47M |
|
$1.39M |
|
$40.07M |
|
$38.22M |
|
$-1.86M |
|
$1.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.84 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-12.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.62% |
|
-14.62% |
|
-13.64% |
|
-14.62% |
|
$0.22 |
|
$-0.07 |
|
$-0.07 |
|